| Serial Number | 79079325 |
| Word Mark | ACLARUSDX |
| Filing Date | Tuesday, November 24, 2009 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Sunday, November 24, 2019 |
| Registration Number | 4021169 |
| Registration Date | Tuesday, September 6, 2011 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, June 21, 2011 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Chemicals and chemical compositions, namely, nucleic acids attached to a solid support for use in industry and science; analyses, namely, reagent for chemical analyses, namely, quantification of nucleic acid content in laboratories chemical preparations for analyses, other than for medical or veterinary use; biological preparations, namely, quantification of nucleic acid content other than for medical or veterinary use, namely, inoculants, namely, biological microorganisms used in fermentation of silage; chemical preparations for scientific use, other than for medical or veterinary use; chemical preparations or reagents for laboratory, other than for medical or veterinary use; chemical preparations for scientific use, namely, nucleic acid libraries to screen and analyze gene expression, to identify therapeutic targets and products, and to conduct pharmacogenomic and genotoxicity research in the fields of pharmacology, food, chemistry, cosmetology, plant protection, and veterinary sciences; chemical preparations for scientific use, namely, DNA biochips for decoding genes affected by the Alzheimer's disease or revealing the transcriptomic signature of patients affected with Alzheimer's disease, and DNA chips to make visible and analyze gene expression in the fields of human and pharmacological medicine and veterinary science |
| Goods and Services | Pharmaceutical preparations for treating neurodegenerative diseases and particularly Alzheimer's disease; tests, namely, a blood based biomarker test to identify patients with Alzheimer's disease or at risk of developing the disease and identifying patients responding to specific treatments; biological products and preparations acids for pharmaceutical use, namely, pharmaceutical preparations for the diagnostic of the Alzheimer's disease; capsules sold empty for medicines and diagnostic tests; chemical-pharmaceutical preparations for the diagnosis, the prevention or the treatment of Alzheimer's disease; biopharmaceutical preparations for the diagnosis, the prevention or the treatment of Alzheimer's disease; chemical preparations for medical, pharmaceutical or veterinary use, namely, for diagnosing neurodegenerative diseases and particularly Alzheimer's disease; medical and clinical diagnostic products, namely, probe sets, namely, subset of nucleic acid sequences and nucleic acid libraries, namely, DNA libraries and RNA libraries; nucleic acid sequences for use on biochips, namely, for decoding genes affected by the Alzheimer's disease or revealing the transcriptomic signature of patients affected with Alzheimer's disease; enzymes or enzyme preparations for medical or veterinary use, namely, enzymes stabilizers, namely, enzymes for medical purposes or veterinary use, namely, for treatment of Alzheimer's disease, enzyme substrates, namely, enzymes for medical purposes or veterinary use, namely, for treatment of Alzheimer's disease used as an ingredient in drugs against Alzheimer's disease |
| Goods and Services | Surgical, medical, dental and veterinary apparatus and instruments, namely, for disease identification, measure of disease severity, measure of disease prognosis, measure of disease progression, measure of disease conversion; medical devices, namely, biochips for analysis of blood; blood testing apparatus; devices, namely, biochips for medical diagnostics uses, namely, biochips for diagnosing Alzheimer's disease, namely, collection kit for blood sampling to perform the test in the right conditions; spoons for administering medicine; receptacles for applying medicines; ultrasound probes for medical use; syringes for medical use; galvanic therapeutic medical devices to diagnose neurodegenerative diseases and particularly Alzheimer's disease |
| Goods and Services | Research and development for third parties in relation to pharmaceutical molecules or biological markers, medicines for the diagnosis and treatment of neurodegenerative diseases; chemical analysis; chemical research; chemical services, namely, analysis of RNA, genes, tissue and blood sample; biotechnology project studies, namely, identifying population of patients affected by the Alzheimer disease and measuring the disease's severity, prognosis, progression and conversion and determining patients sensitivity to treatment; research and development of new products for third parties; biological research; research in biotechnology; technical research in the field of biotechnology; biotechnology analysis services |
| Goods and Services | Medical services; veterinary services; medical assistance services; providing medical information, consultancy and advisory services; hospital services; pharmacists' services relating to the pharmaceutical industry, namely, the filling of and making up prescriptions; health care; telemedicine services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, December 5, 2014 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, December 5, 2014 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, December 5, 2014 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, December 5, 2014 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, December 5, 2014 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EXONHIT S.A. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | FR |
| Party Name | ExonHit Therapeutics |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | FR |
| Party Name | ExonHit Therapeutics |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | FR |
| Event Date | Event Description |
| Saturday, December 12, 2020 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Saturday, December 12, 2020 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, September 25, 2015 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Wednesday, September 2, 2015 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Wednesday, September 2, 2015 | INVALIDATION PROCESSED |
| Wednesday, August 5, 2015 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, December 5, 2014 | CANCELLED SECTION 7-TOTAL |
| Friday, December 5, 2014 | CANCELLATION TERMINATED NO. 999999 |
| Wednesday, December 3, 2014 | CANCELLATION DENIED NO. 999999 |
| Friday, October 24, 2014 | CANCELLATION INSTITUTED NO. 999999 |
| Sunday, May 19, 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, March 8, 2012 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, March 8, 2012 | FINAL DISPOSITION PROCESSED |
| Sunday, December 18, 2011 | NOTIFICATION PROCESSED BY IB |
| Tuesday, December 6, 2011 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Saturday, October 15, 2011 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Tuesday, September 6, 2011 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, September 3, 2011 | NOTIFICATION PROCESSED BY IB |
| Wednesday, August 17, 2011 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, August 17, 2011 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, June 21, 2011 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 21, 2011 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 1, 2011 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 1, 2011 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Thursday, May 19, 2011 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, May 19, 2011 | ASSIGNED TO LIE |
| Friday, May 6, 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 8, 2011 | ASSIGNED TO EXAMINER |
| Tuesday, February 8, 2011 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, February 8, 2011 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 8, 2011 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 8, 2011 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, August 9, 2010 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, August 9, 2010 | FINAL REFUSAL E-MAILED |
| Monday, August 9, 2010 | FINAL REFUSAL WRITTEN |
| Monday, July 12, 2010 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, July 12, 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 12, 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 12, 2010 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 30, 2010 | REFUSAL PROCESSED BY IB |
| Friday, March 19, 2010 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, March 19, 2010 | REFUSAL PROCESSED BY MPU |
| Friday, March 19, 2010 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, March 19, 2010 | APPLICATION FILING RECEIPT MAILED |
| Thursday, March 18, 2010 | NON-FINAL ACTION WRITTEN |
| Monday, March 15, 2010 | ASSIGNED TO EXAMINER |
| Monday, March 15, 2010 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, March 11, 2010 | SN ASSIGNED FOR SECT 66A APPL FROM IB |